These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8091675)

  • 21. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mutations in rev gene of SIVmac on virus replication.
    Aavik E; Hakkarainen K; Krohn KJ
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S123-8. PubMed ID: 7865286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B; Stutz F; Rosbash M
    J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionality of chimeric Rev proteins of HIV/SIV.
    Furuta RA; Sakai H; Kawamura M; Tokunaga K; Hatanaka M; Adachi A
    Virus Genes; 1995; 11(1):11-14. PubMed ID: 8808329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.
    Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E
    Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239.
    Alexander L; Denekamp L; Czajak S; Desrosiers RC
    J Virol; 2001 Apr; 75(8):4019-22. PubMed ID: 11264395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A trans-dominant negative HIV type 1 Rev with intact domains of NLS/NOS and NES.
    Fang J; Kubota S; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2002 Jul; 18(10):705-9. PubMed ID: 12167277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
    Bogerd H; Greene WC
    J Virol; 1993 May; 67(5):2496-502. PubMed ID: 8474155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementation of the rev gene mutation among human and simian lentiviruses.
    Sakai H; Shibata R; Miura T; Hayami M; Ogawa K; Kiyomasu T; Ishimoto A; Adachi A
    J Virol; 1990 May; 64(5):2202-7. PubMed ID: 2182909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
    Malim MH; Freimuth WW; Liu J; Boyle TJ; Lyerly HK; Cullen BR; Nabel GJ
    J Exp Med; 1992 Oct; 176(4):1197-201. PubMed ID: 1402661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2.
    Garrett ED; Cullen BR
    J Virol; 1992 Jul; 66(7):4288-94. PubMed ID: 1602545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.
    Malim MH; Böhnlein S; Fenrick R; Le SY; Maizel JV; Cullen BR
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8222-6. PubMed ID: 2682638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.
    Lewis N; Williams J; Rekosh D; Hammarskjöld ML
    J Virol; 1990 Apr; 64(4):1690-7. PubMed ID: 2157051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletions near the N-terminus of HIV-1 Rev reduce RNA binding affinity and dominantly interfere with Rev function irrespective of the RNA target.
    Jeong KS; Nam YS; Venkatesan S
    Arch Virol; 2000; 145(12):2443-67. PubMed ID: 11205098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.